000 | 02158 a2200553 4500 | ||
---|---|---|---|
005 | 20250515224303.0 | ||
264 | 0 | _c20100923 | |
008 | 201009s 0 0 eng d | ||
022 | _a1521-0103 | ||
024 | 7 |
_a10.1124/jpet.110.168153 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChiou, Shiun-Kwei | |
245 | 0 | 0 |
_aSuppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 2010 |
||
300 |
_a693-702 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtoxicity |
650 | 0 | 4 |
_aAntisense Elements (Genetics) _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCaspase 9 _xmetabolism |
650 | 0 | 4 | _aCaspase Inhibitors |
650 | 0 | 4 |
_aCell Cycle Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCyclooxygenase 1 _xmetabolism |
650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xpharmacology |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 |
_aDinoprostone _xpharmacology |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aGastric Mucosa _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndomethacin _xtoxicity |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aNuclear Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aStomach Ulcer _xchemically induced |
650 | 0 | 4 |
_aSulindac _xtoxicity |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aHodges, Amy | |
700 | 1 | _aHoa, Neil | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 334 _gno. 3 _gp. 693-702 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.110.168153 _zAvailable from publisher's website |
999 |
_c19851120 _d19851120 |